SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001437749-19-019919
Filing Date
2019-10-10
Accepted
2019-10-10 16:54:50
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM 424B3 dffn20191009_424b3.htm 424B3 225491
2 a01.jpg GRAPHIC 42818
3 a02.jpg GRAPHIC 76614
4 a03.jpg GRAPHIC 76621
5 d01.jpg GRAPHIC 24158
6 logo9.jpg GRAPHIC 21091
  Complete submission text file 0001437749-19-019919.txt   559495
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-233686 | Film No.: 191146551
SIC: 2834 Pharmaceutical Preparations